Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling

Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling

  • CN 101,379,087 A
  • Filed: 11/30/2006
  • Published: 03/04/2009
  • Est. Priority Date: 12/02/2005
  • Status: Active Application
First Claim
Patent Images

1. a specific specificity is in conjunction with the antibody of IL-22, and wherein said antibody is:

  • (a) antibody that produces by the hybridoma that is selected from 3F11.3 (ATCC registration number PTA-7312), hybridoma 11H4.4 (ATCC registration number PTA-7315) and hybridoma 8E11.9 (ATCC registration number PTA-7319);

    (b) the affine sophisticated form of antibody (a);

    (c) (a) or antigen-binding fragments of antibodies (b);

    Or(d) the humanization form of (a) and (b) or antibody (c).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×